- Home
- SHOT vs ASRT Comparison
SHOT vs ASRT Comparison
Compare SHOT & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOT
- ASRT
- Stock Information
- Founded
- SHOT 2018
- ASRT 1995
- Country
- SHOT United States
- ASRT United States
- Employees
- SHOT N/A
- ASRT N/A
- Industry
- SHOT Biotechnology: Pharmaceutical Preparations
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- SHOT Health Care
- ASRT Health Care
- Exchange
- SHOT Nasdaq
- ASRT Nasdaq
- Market Cap
- SHOT 83.7M
- ASRT 79.1M
- IPO Year
- SHOT 2020
- ASRT 1997
- Fundamental
- Price
- SHOT $0.37
- ASRT $0.91
- Analyst Decision
- SHOT
- ASRT Strong Buy
- Analyst Count
- SHOT 0
- ASRT 1
- Target Price
- SHOT N/A
- ASRT $3.00
- AVG Volume (30 Days)
- SHOT 11.3M
- ASRT 317.6K
- Earning Date
- SHOT 11-13-2025
- ASRT 11-10-2025
- Dividend Yield
- SHOT N/A
- ASRT N/A
- EPS Growth
- SHOT N/A
- ASRT N/A
- EPS
- SHOT N/A
- ASRT N/A
- Revenue
- SHOT N/A
- ASRT $117,099,000.00
- Revenue This Year
- SHOT N/A
- ASRT N/A
- Revenue Next Year
- SHOT N/A
- ASRT $6.75
- P/E Ratio
- SHOT N/A
- ASRT N/A
- Revenue Growth
- SHOT 246.36
- ASRT N/A
- 52 Week Low
- SHOT $0.23
- ASRT $0.51
- 52 Week High
- SHOT $1.35
- ASRT $1.16
- Technical
- Relative Strength Index (RSI)
- SHOT 51.76
- ASRT 58.21
- Support Level
- SHOT $0.25
- ASRT $0.87
- Resistance Level
- SHOT $0.33
- ASRT $0.93
- Average True Range (ATR)
- SHOT 0.04
- ASRT 0.05
- MACD
- SHOT 0.01
- ASRT -0.00
- Stochastic Oscillator
- SHOT 72.47
- ASRT 54.32
About SHOT Safety Shot Inc.
Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.